Loading clinical trials...
Loading clinical trials...
Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX
Conditions
Interventions
Capecitabine
Fluorouracil
+6 more
Locations
1
United States
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Start Date
February 11, 2021
Primary Completion Date
October 1, 2026
Completion Date
October 15, 2027
Last Updated
March 30, 2026
NCT06696768
NCT04929028
NCT04511039
NCT06051695
NCT06778863
NCT06312982
Lead Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions